Clinical Microbiology Newsletter
Volume 31, Issue 17 , Pages 129-136 , 1 September 2009

The Impact of Clinical Laboratory Improvement Advisory Committee Recommendations on Microbiology Laboratories

  • Nancy L. Anderson, M.M.Sc.

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, Georgia
    • Corresponding Author InformationCorresponding author: Nancy L. Anderson, M.M.Sc., Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop F-11, Atlanta, GA 30329-4018. Tel.: 404-498-2741. Fax: 404-498-2219
  • ,
  • Diane C. Bosse, M.S.
  • ,
  • Alice S. Weissfeld, Ph.D., D(ABMM), F(AAM)

      Affiliations

    • Microbiology Specialists Incorporated, Houston, Texas

References 

  1. Clinical Laboratory Improvement Amendments of 1988. 42 U.S.C. 263a. PL100-578.
  2. Clinical Laboratory Improvement Act of 1967. 42 U.S.C. 263. PL90-174.
  3. Centers for Medicare and Medicaid Services, Department of Health and Human Services. 1992. Laboratory requirements. 42 CFR. Chapter IV, Part 493.
  4. Centers for Medicare and Medicaid Services, Department of Health and Human Services. 2003. Laboratory requirements. 42 CFR. Chapter IV, Part 493.
  5. Centers for Disease Control and Prevention  . Charter & The Clinical Laboratory Improvement Advisory Committee . http://wwwn.cdc.gov/cliac/pdf/CliacCharter2008.pdf
  6. The Federal Advisory Committee Act of 1972. PL92-463.
  7. Clinical and Laboratory Standards Institute  . Quality control requirements for commercial microbial identification systems; approved guideline. Publication no. M50-A . Wayne, PA: CLSI; 2008;
  8. The Medical Laboratory Personnel Shortage Act of 2001. H.R. 1948. 107th Congress, 1st Session.

PII: S0196-4399(09)00039-7

doi: 10.1016/j.clinmicnews.2009.08.001

Clinical Microbiology Newsletter
Volume 31, Issue 17 , Pages 129-136 , 1 September 2009